Records containing: Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2023-07-19
A Randomized, Phase II Study of Ficlatuzumab With or Without Cetuximab in Patients With Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
CLINICAL_TRIALS study record update · 2020-07-29
A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection
CLINICAL_TRIALS study record update · 2020-03-19
A Phase II Study of Capecitabine and Lapatinib in Squamous Cell Carcinoma of the Head and Neck
CLINICAL_TRIALS study record update · 2018-10-02
A Phase I/II Study Of Bevacizumab (rhuMAb VEGF) In Combination With OSI-774 For Patients With Recurrent Or Metastatic Cancer Of The Head And Neck
CLINICAL_TRIALS study record update · 2018-02-26
Phase II Trial of Carboplatin/Paclitaxel and Cetuximab, Followed by Carboplatin/Paclitaxel/Cetuximab and Erlotinib, With Correlative Studies in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck.
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2015-09-30
A Phase I Clinical and Biological Evaluation of Combined EGFR Blockade With Erlotinib and Cetuximab in Patients With Advanced Cancer
CLINICAL_TRIALS study record update · 2014-08-22
Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trial of Selenomethionine as a Modulator of Efficacy and Toxicity of Chemoradiation in Locally-Advanced Squamous Cell Carcinoma of the Head and Neck
CLINICAL_TRIALS study record update · 2014-06-11
A Phase I, and Biologic Correlative Study of Erlotinib, in Combination With Cetuximab and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma
CLINICAL_TRIALS study record update · 2014-01-22
Phase II Study of Sunitinib Malate in Head and Neck Squamous Cell Carcinoma
CLINICAL_TRIALS study record update · 2014-01-07
A Phase II Study Of GW572016 In Squamous Cell Carcinoma Of The Head And Neck (SCCHN)
CLINICAL_TRIALS study record update · 2013-11-25
A Phase I and Phase II Study of OSI-774 in Combination With Docetaxel in Squamous Cell Carcinoma of the Head and Neck
CLINICAL_TRIALS study record update · 2013-09-30
A Phase I Study of UCN-01 in Combination With Irinotecan in Resistant Solid Tumor Malignancies (Part I) and in Triple Negative (ER-Negative, PgR-Negative, HER-2 Not-Amplified) Recurrent Breast Cancers (Part II)
CLINICAL_TRIALS study record update · 2013-07-02
A Phase I Trial of Concurrent Chemoradiation/Chemoreirradiation With Cetuximab (ERBITUX®), Sunitinib, and Accelerated Radiation in Patients With Locally Advanced/High-risk/Recurrent Poor Prognosis Head and Neck Cancer
CLINICAL_TRIALS study record update · 2013-06-14
A Randomized Phase II Trial of Bevacizumab to Control Brain Radiation Damage
CLINICAL_TRIALS study record update · 2013-04-10
Phase 1 Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG, NSC #707545) in Patients With Solid Tumors.
CLINICAL_TRIALS study record update · 2013-02-07
A Phase I Study Of Bevacizumab (Recombinant Humanized Monoclonal Antibody To Vascular Endothelial Growth Factor) In Addition To Flourouracil And Hydroxyurea As Initial Chemotherapy With Concomitant Radiotherapy (B-FHX) For Poor Prognosis Head And Neck Cancer
CLINICAL_TRIALS study record update · 2013-01-24
A Phase I Study Of PV701 In Patients With Head And Neck Squamous Cell Carcinoma
CLINICAL_TRIALS study record update · 2013-01-16
Phase I Study of OSI-774 (NSC 718781) for Solid Tumors in Patients With Hepatic or Renal Dysfunction